Article
In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants.
Antimicrobial agents and chemotherapy - 1 Jun 2007
Brunelle M N, Lucifora J, Neyts J, Villet S, Holy A, Trepo C, Zoulim F
Abstract excerpt
The susceptibilities of drug-resistant hepatitis B virus (HBV) mutants to lamivudine, adefovir, tenofovir, entecavir, and 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine (PMEO-DAPym), a novel acyclic pyrimidine analogue, were assessed in vitro. Most drug-resistant mutants, including multidrug-resistant strains, remained sensitive to tenofovir and PMEO-DAPym. Therefore, the latter molecule deserves further...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
